Ask AI

Search

Updates

Loading...

Home

New Question

Do I need to screen psoriasis patients for cvd?

Answer

Patients with psoriasis should be screened for cardiovascular disease (CVD). The American Academy of Dermatology and National Psoriasis Foundation (AAD/NPF) 2019 guidelines recommend screening for hypertension, diabetes, and hyperlipidemia in all patients with psoriasis according to national guidelines
1
Guidelines

1.

Screening for CVD

Pathway
AAD/.../NPF 2019
.

Cardiovascular disease screening recommendations

  • Hypertension: The AAD/NPF 2019 guidelines recommend checking blood pressure in patients with mild, moderate, or severe psoriasis according to national guidelines. Patients with a blood pressure of ≥ 140/90 mmHg should be referred to their primary care provider for assessment and treatment
  • Diabetes and hyperlipidemia: The guidelines recommend obtaining early and more frequent screening for these conditions in patients with psoriasis who are candidates for systemic or phototherapy or in patients with an involvement of > 10% of the body surface area
  • Cardiovascular risk assessment: The guidelines recommend assessing cardiovascular risk by introducing a 1.5 multiplication factor to risk score models for patients with psoriasis who meet either of the following criteria: disease severity of body surface area > 10% or candidate for systemic or phototherapy
  • Management of cardiovascular risk: The guidelines recommend managing cardiovascular risk in psoriasis for hypertension and dyslipidemia according to national guidelines. A target for blood pressure and lipid levels should be set based on the risk calculated for psoriasis

Metabolic syndrome screening recommendations

In conclusion, patients with psoriasis should be screened for cardiovascular disease and metabolic syndrome according to national guidelines. This is due to the increased risk of cardiovascular disease in this patient population, particularly those with moderate to severe disease
9
Abstract

9.

Psoriasis: an opportunity to identify cardiovascular risk

PubMed
High-impact
. Regular follow-up and monitoring are essential to manage both psoriasis and associated cardiovascular risks effectively.

References

1

Psoriasis

Diagnostic investigations

Guidelines

Screening for CVD

Pathway
AAD/.../NPF 2019